Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema

Ophthalmology

Volumn 121, Issue 9, 2014, Pages 1783-1789

  Campochiaro, Peter A ^a   Wykoff, Charles C ^b   Shapiro, Howard ^c   Rubio, Roman G ^c   Ehrlich, Jason S ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b RETINA CONSULTANTS OF HOUSTON   (United States)

^c GENENTECH INC   (United States)

Author keywords

Abbreviations and Acronyms; branch retinal vein occlusion; BRVO; central retinal vein occlusion; CRVO; DA; diabetic macular edema; disc area; DME; Early Treatment Diabetic Retinopathy Study; ETDRS; ranibizumab; RBZ; retinal nonperfusion; retinal vein occlusion; RNP; RVO; vascular endothelial growth factor; VEGF

Indexed keywords

RANIBIZUMAB; VASCULOTROPIN;

ADULT; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSTERIOR RETINAL NONPERFUSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RETINA CAPILLARY; RETINA DISEASE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA HEMORRHAGE; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; SMOKING;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DIABETIC RETINOPATHY; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84906940176     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2014.03.021     Document Type: Conference Paper

References (33)

1. R. Klein, and B.E. Klein Vision disorders in diabetes M.I. Harris, C.C. Cowie, M.P. Stern, Diabetes in America 2nd ed. 1995 National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health Bethesda, MD 293 338 NIH publication no. 95-1468. Available at: http://diabetes.niddk.nih.gov/dm/pubs/america/contents.aspx. Accessed March 4, 2014
2. R. Klein, M.D. Knudtson, and K.E. Lee et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes Ophthalmology 116 2009 497 503
3. R. Engerman, J.M. Bloodworth Jr., and S. Nelson Relationship of microvascular disease in diabetes to metabolic control Diabetes 26 1977 760 769
4. Diabetes Control and Complications Trial Research Group Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial Ophthalmology 102 1995 647 661
5. W.G. Robison Jr., M.L. McCaleb, and L.G. Feld et al. Degenerated intramural pericytes ('ghost cell') in the retinal capillaries of diabetic rats Curr Eye Res 10 1991 339 350
6. Q.D. Nguyen, S.M. Shah, and E. Van Anden et al. Supplemental oxygen improves diabetic macular edema: a pilot study Invest Ophthalmol Vis Sci 45 2004 617 624
7. P.A. Campochiaro C99-PKC412-003 Study Group. Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412 Invest Ophthalmol Vis Sci 45 2004 922 931
8. Q.D. Nguyen, S. Tatlipinar, and S.M. Shah et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema Am J Ophthalmol 142 2006 961 969
9. Diabetic Retinopathy Clinical Research Network, M.J. Elman, L.P. Aiello, and R.W. Beck et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Ophthalmology 117 2010 1064 1077
10. P. Mitchell, F. Bandello, U. Schmidt-Erfurth RESTORE Study Group The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema Ophthalmology 118 2011 615 625
11. Q.D. Nguyen, D.M. Brown, D.M. Marcus RISE and RIDE Research Group Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE Ophthalmology 119 2012 789 801
12. D.M. Brown, Q.D. Nguyen, D.M. Marcus RIDE and RISE Research Group Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE Ophthalmology 120 2013 2013 2022
13. P.A. Campochiaro, G. Hafiz, and S.M. Shah et al. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator Mol Ther 16 2008 791 799
14. P.A. Campochiaro, J.S. Heier, L. Feiner BRAVO Investigators Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary endpoint results of a phase III study Ophthalmology 117 2010 1102 1112
15. D.M. Brown, P.A. Campochiaro, R.P. Singh CRUISE Investigators Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1124 1133
16. P.A. Campochiaro, D.M. Brown, and C.C. Awh et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study Ophthalmology 118 2011 2041 2049
17. D.M. Brown, P.A. Campochiaro, and R.B. Bhisitkul et al. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study Ophthalmology 118 2011 1594 1602
18. E.J. Sabet-Peyman, F.M. Heussen, and J.E. Thorne et al. Progression of macular ischemia following intravitreal bevacizumab Ophthalmic Surg Lasers Imaging 40 2009 316 318
19. A.M. Mansour, L.A. Bynoe, and J.C. Welch et al. Retinal vascular events after intravitreal bevacizumab Acta Ophthalmol 88 2010 730 735
20. M. Shimura, and K. Yasuda Macular ischaemia after intravitreal bevacizumab injection in patients with central retinal vein occlusion and a history of diabetes and vascular disease [letter] Br J Ophthalmol 94 2010 381 383
21. N.R. Kim, and H.S. Chin Progression of impending central retinal vein occlusion to the ischemic variant following intravitreal bevacizumab Korean J Ophthalmol 24 2010 179 181
22. M. Battaglia Parodi, P. Iacono, and M.L. Cascavilla et al. Sequential anterior ischemic optic neuropathy and central retinal artery and vein occlusion after ranibizumab for diabetic macular edema Eur J Ophthalmol 20 2010 1076 1078
23. T. Terui, M. Kondo, and T. Sugita et al. Changes in areas of capillary nonperfusion after intravitreal injection of bevacizumab in eyes with branch vein occlusion Retina 31 2011 1068 1074
24. N. Goel, V. Kumar, and B. Ghosh Ischemic maculopathy following intravitreal bevacizumab for refractory diabetic macular edema Int Ophthalmol 31 2011 39 42
25. P.A. Campochiaro, R.B. Bhisitkul, H. Shapiro, and R.G. Rubio Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion Ophthalmology 120 2013 795 802
26. Q.D. Nguyen, S.M. Shah, A.A. Khwaja READ-2 Study Group Two-year outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) study Ophthalmology 117 2010 2146 2151
27. Early Treatment Diabetic Retinopathy Study Research Group Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1 Arch Ophthalmol 103 1985 1796 1806
28. Early Treatment Diabetic Retinopathy Study Research Group Classification of diabetic retinopathy from fluorescein angiograms: ETDRS report number 11 Ophthalmology 98 suppl 1991 807 822
29. B.A. Blodi, A. Domalpally, I.U. Scott SCORE Study Research Group Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE study report 9 Arch Ophthalmol 128 2010 1140 1145
30. Early Treatment Diabetic Retinopathy Study Group Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report no 12 Ophthalmology 98 suppl 1991 823 833
31. M.S. Ip, A. Domalpally, and J.J. Hopkins et al. Long-term effects of ranibizumab on diabetic retinopathy severity and progression Arch Ophthalmol 130 2012 1145 1152
32. M.J. Tolentino, J.W. Miller, and E.S. Gragoudas et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate Ophthalmology 103 1996 1820 1828
33. P.A. Campochiaro, D.M. Brown, A. Pearson FAME Study Group Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema Ophthalmology 118 2011 626 635